Qubit Pharmaceuticals
About
Qubit Pharmaceuticals is a Paris and Boston-based quantum-enhanced drug discovery company founded in 2020 that accelerates pharmaceutical research using hybrid quantum-classical computing through their Atlas platform, achieving molecular simulations 100,000 times faster than traditional methods while reducing drug candidate screening from 5,000 to 200 compounds, with breakthrough technologies including the Hyperion-1 quantum emulator simulating 40 qubits and the FeNNix-Bio1 quantum AI foundation model developed with Sorbonne University, operating one of France's largest GPU supercomputers and advancing 7 therapeutic programs particularly in oncology and inflammation.
Categories
Key People
Robert Marino (Co-founder, CEO), Louis-Paul Henry (Co-founder, CTO)
Mentions on QuantumZeitgeist
Qubit Pharmaceuticals. How AI-Powered Quantum Chemistry is Transforming Molecular Simulations
quantumzeitgeist.com
Qubit Pharmaceuticals Achieves Quantum Breakthrough with 40-Qubit Simulations in Drug Discovery
quantumzeitgeist.com
Qubit Pharmaceuticals Unveils Quantum Chemistry Breakthrough, Potentially Revolutionising Drug Discovery and Material Design
quantumzeitgeist.com
Pasqal and Qubit Pharmaceuticals Win $4.5M for Quantum Drug Discovery
quantumzeitgeist.com
Request Information
Interested in Qubit Pharmaceuticals? Get pricing, demos, or technical details.
Request Information
Get in touch with Qubit Pharmaceuticals about your project.
Claim This Profile
Are you from Qubit Pharmaceuticals? Verify your association to update your listing and receive notifications.
Claim Your Profile
Verify you represent Qubit Pharmaceuticals to update your listing.
Quick Facts
Links
Location
Loading map...
Stay Updated
Get the latest quantum computing news delivered to your inbox.